➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

CAPREOMYCIN SULFATE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for capreomycin sulfate and what is the scope of freedom to operate?

Capreomycin sulfate is the generic ingredient in two branded drugs marketed by Akorn, Hisun Pharm Hangzhou, and Mylan Labs Ltd, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for capreomycin sulfate. One supplier is listed for this compound.

Recent Clinical Trials for CAPREOMYCIN SULFATE

Identify potential brand extensions & 505(b)(2) entrants

National Institute of Allergy and Infectious Diseases (NIAID)N/A

See all CAPREOMYCIN SULFATE clinical trials

Medical Subject Heading (MeSH) Categories for CAPREOMYCIN SULFATE

US Patents and Regulatory Information for CAPREOMYCIN SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn CAPASTAT SULFATE capreomycin sulfate INJECTABLE;INJECTION 050095-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Mylan Labs Ltd CAPREOMYCIN SULFATE capreomycin sulfate INJECTABLE;INJECTION 202634-001 Nov 27, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
Hisun Pharm Hangzhou CAPREOMYCIN SULFATE capreomycin sulfate INJECTABLE;INJECTION 204796-001 Oct 18, 2018 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.